Acquiring Company
Schneider Electric
Acquired Company
PTC Therapeutics
Paris
South PlainfieldManufacturingEnergymachineryBiotechnologyDescription
Schneider Electric has agreed to acquire PTC in an all-cash deal valued at $23.7 billion, significantly enhancing its software capabilities. The transaction offers PTC shareholders a premium of 42.3% at $205 per share. The deal is expected to close in the third quarter of 2027 and will be financed through equity and new debt issuance.
Fundz sees it the moment Schneider Electric makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired PTC Therapeutics?
PTC Therapeutics was acquired by Schneider Electric, based in Paris. The deal was reported on October 5, 2026. Schneider Electric is a global specialist in energy management and automation, committed to making energy safe, reliable, efficient, and sustainable. Schneider Electric is privately held and operates in Manufacturing.
When did Schneider Electric acquire PTC Therapeutics?
Schneider Electric's acquisition of PTC Therapeutics was reported on October 5, 2026. Schneider Electric has agreed to acquire PTC in an all-cash deal valued at $23.7 billion, significantly enhancing its software capabilities. The transaction offers PTC shareholders a premium of 42.3% at $205 per share. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does PTC Therapeutics do?
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs. It is publicly traded (PTCT), operating in Biotechnology, and is based in South Plainfield.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.